Home Dialysis Virtual Education Faculty & Moderators
Dr Graham Abra is a Clinical Assistant Professor at Stanford University and served as the Chief Medical Officer, Home Therapies at Satellite Healthcare. He completed medical school and Internal Medicine training at the University of California, San Diego where he spent an additional year as the Chief Medical Resident. He completed nephrology fellowship at Stanford University and spent two years at the Stanford Clinical Excellence Research Center. His current clinical practice focuses on the care of patients with advanced Chronic Kidney Disease and the management of home dialysis. He served as the Medical Director of WellBound San Jose, a home dialysis facility for half a decade and has worked in a variety of administrative roles at Satellite Healthcare for 10 years including serving as the Medical Director of the organizations ESRD Medicare Advantage Special Needs Plan. He is a member of the PDOPPS US Advisory Workgroup, has been a site investigator for both the Tablo and Quanta SC+ home hemodialysis Investigational Device Exemption trials, is Associate Editor of Nephrology News & Issues, Chairs the Home Dialysis Academy of Excellence and is on the NephJC Advisory team.
Advisory or Leadership Role: Nephrology News & Issues Associate Editor (unpaid); PDOPPS US Advisory Group member (unpaid); Co-Chair of ASN HDU Virtual Education Program Workgroup (unpaid)
Joanne Bargman is a staff nephrologist at the University Health Network and Professor of Medicine at the University of Toronto. She received her MD cum laude from the University of Toronto. She pursued nephrology training at Stanford University. Her research focused on renal physiology and micropuncture. Upon returning to Toronto, she was recruited to the Toronto Western Hospital where she trained in peritoneal dialysis under Dimitrios Oreopoulos. She has more than 900 invited lectures internationally, on subjects as diverse as peritoneal dialysis, glomerulonephritis, and management of lupus. She is Director of Peritoneal Dialysis for the University Health Network in Toronto, Past-President of the International Society of Peritoneal Dialysis, and co-director of the Combined Renal-Rheumatology Lupus Clinic for the University Health Network.
She has won the “Silver Shovel”, given by the graduating medical class of the University of Toronto to the best lecturer in the undergraduate years. She has also won the University of Toronto Faculty of Medicine Postgraduate Teaching Award, given to the best teacher in the postgraduate program. In 2013 she was the recipient of both the Donald Seldin Award for excellence in nephrology at the National Kidney Foundation (US) and the award for teaching excellence from the Canadian Society of Nephrology. She was the 2015 Recipient of the Lifetime Achievement Award at the Annual Dialysis Conference in New Orleans, and received the International Distinguished Medal at the Spring Clinical Meetings of the National Kidney Foundation in 2016. In 2018 she was the recipient of the Gabor Zellerman Award for Research and Excellence in Peritoneal Dialysis. In 2021 she was awarded the Robert G. Narins Lifetime Achievement Award from the American Society of Nephrology. She is an Associate Editor of the Journal of the American Society of Nephrology. Dr. Bargman is co-author of the chapter “Chronic Kidney Disease” in the 17th, 18th, 19th, 20th and 21st editions of Harrison’s Principles of Internal Medicine.
Employer: University Health Network
Consultancy: DaVita Healthcare Partners; Glaxo Smith Kline; , Bayer, Otsuka
Honoraria: Baxter Healthcare, Davita Healthcare Partners, ,Glaxo Smith Kline
Advisory or Leadership Role: Editorial Boards: , Journal of the American Society of Nephrology, Peritoneal Dialysis International, Clinical Journal of the American Society of Nephrology
Speakers Bureau: DaVita Healthcare Partners, Baxter Canada, Baxter Global, Glaxo Smith Kline
Other Interests or Relationships: Editorial Board, UpToDate
Dr. Christopher Chan is presently Director of the Division of Nephrology, Professor of Medicine and holds the R Fraser Elliott Chair in Nephrology. Dr. Chan is the Deputy Physician in Chief of Economics and the Medical Lead of Connected Care at the University Health Network. He also serves as Associate Editor for the Clinical Journal of the American Society of Nephrology and is the President of the International Society for Hemodialysis.
He has contributed over 250 peer-reviewed articles and has written multiple book chapters in the field of home dialysis. His current research interests include the clinical, genomic physiological changes of intensive hemodialysis, cardiovascular disease in chronic kidney disease and sleep disorders in patients with end-stage renal disease. He has championed and defined clinical use of home dialysis, leading and coordinating a large network dedicated to the clinical and basic science aspects of optimal dialysis delivery. Dr. Chan have received multiple awards and was recently honored by Temerty Faculty of Medicine 2020 Dean’s Award for his leadership and impact on renal replacement therapy. (Honouring Impact: The 2020 Dean’s Alumni Awards | Faculty of Medicine (utoronto.ca))
Employer: Toronto General Hospital, University Health Network
Consultancy: Medtronic, Quanta, Dialco
Research Funding: Medtronic through their external grant program
Advisory or Leadership Role: Medtronic, Quanta, DaVita
Joel D. Glickman, MD is a Professor of Clinical Medicine at the Perlman School of Medicine of The University of Pennsylvania, where he is Director of the Home Dialysis Programs. He attended Downstate Medical School, did his internal medicine residency at Montefiore Hospital in the Bronx, and completed his fellowship in nephrology at the Hospital of The University of Pennsylvania. His academic interests focus on clinical outcomes and education in home hemodialysis and peritoneal dialysis. Dr. Glickman has been named “Top Doc” in Philadelphia Magazine and in U.S. News and World Report. Nationally, he frequently lectures on chronic kidney disease, home hemodialysis and peritoneal dialysis. He has received several teaching awards, including the Edward D. Viner Teaching Award at Pennsylvania Hospital, and is a three-time recipient of the J. Russell Elkinton Faculty Teaching Award from the Renal-Electrolyte Division at the University of Pennsylvania. Recently, he was appointed Course Director for Home Dialysis University.
Employer: University of Pennsylvania
Consultancy: Outset Medical
Honoraria: Home Dialysis University (ISPD); UpToDate
Dr. Golper was recruited to Vanderbilt University Medical Center (VUMC) as a Professor in 1999. His prior international experience included organizational memberships, being an Honorary Consultant to the UK National Health Service during his role at The European Dialysis and Transplant Registry in London, serving as the secretary of the International Society of Blood Purification and organizing its 1992 meeting. He co-founded the International Society of Peritoneal Dialysis (ISPD) Ad Hoc Committee on Peritonitis.
Nationally, he chaired the Peritoneal Dialysis Adequacy Work Group of the Dialysis Outcome Quality Initiative, served on the initial Data Management Committee at the inception of the United States Renal Data System, helped establish what is now Home Dialysis University (HDU), served on the Boards of the Renal Physicians Association and the American Association of Kidney Patients, served as president of the Louisville, Kentucky, chapter of the National Kidney Foundation, served on several committees of the American Society of Nephrology, NIH and FDA, and was chief medical officer of Disease Management Inc.
He was recruited to VUMC to specifically address facility and physician revenue operational issues. He formed and led the Department of Medicine’s Divisional Coding Expert Committee, working closely with the VUMC Office of Compliance. He performed the analyses and then was a leader in the creation of the Vanderbilt East Dialysis Facility. He was assigned to improve upon and grow the Home Dialysis Program.
He hosted the ISPD North American Chapter 2013 meeting. He later received its Zellerman award and became president. In 2017 he became the course director for HDU. He received the Nephrology Division outstanding faculty award 3 times while maintaining a busy nephrology practice.
He was an associate editor of Clinical Nephrology and Blood Purification, section editor in Up To Date and on the review board of many journals. In July of 2023 he was awarded emeritus status at VUMC and he is currently part time Professor of Medicine at the Robert Larner College of Medicine at the University of Vermont.
Consultancy: NxStage; Lightline
Research Funding: Renal Research Institute
Honoraria: Up To Date; NxStage; Renal Research Institute, , Home Dialysis University
Patents or Royalties: Up to Date
Advisory or Leadership Role: NxStage; LightLine Medical,: Home Dialysis University
Other Interests or Relationships: Section Editor for Dialysis Up To Date; Executive Committee Home Dialysis University
Dr. Janice P. Lea, MD, MSc, FASN is a Professor of Medicine at Emory University and is board-certified in Nephrology and Hypertension. Dr. Lea is the Clinical Director of Nephrology and of Telenephrology as well as Chief Medical Director of Emory Dialysis, including Home Dialysis therapies. She earned her medical degree at the University of Texas Medical Branch at Galveston and completed her residency in Internal Medicine and a Nephrology fellowship at Emory. Dr. Lea’s research and clinical expertise are in Hypertension, Chronic Kidney Disease, Kidney Health Disparities, and in Dialysis outcomes. She is an active member of the American Society of Nephrology and an executive board member of the American Association of Kidney Patients. She recently was appointed to the American Board of Internal Medicine (ABIM) Nephrology board in 2022. She has served as faculty for the Home Dialysis University since 2010 and is a member of the ASN-HDU taskforce committee for Nephrology fellow Home Dialysis education. Dr. Lea also has been named one of Atlanta’s Top Doctors for the last 10 years.
Employer: Emory University
Dr. Mehrotra, is Belding H. Scribner Endowed Professor and Head of the Division of Nephrology in the Department of Medicine at the University of Washington School of Medicine. He is the Editor-in-Chief of the Clinical Journal of the American Society of Nephrology and the President-Elect for the International Society for Peritoneal Dialysis.
He is a physician-scientist and his research and clinical work is focused broadly on improving the lived experience of people with advanced kidney disease. His research work, funded by both the NIH and PCORI, has advanced our understanding of the barriers to a greater use of home dialysis, biologic determinants of peritoneal dialysis, and clinical trials to test interventions for managing symptoms experienced by patients undergoing long-term dialysis. He has co-authored over 300 original research papers and book chapters.
Dr. Mehrotra completed his medical schooling at the All India Institute of Medical Sciences in New Delhi India, where he also underwent residency training. He received further residency training at the Medical College of Pennsylvania, Philadelphia, and nephrology fellowship training at the University of Missouri-Columbia. He obtained a Masters of Science in Clinical Research at the University of California, Los Angeles.
Employer: University of Washington School of Medicine, Seattle, WA
Advisory or Leadership Role: Editor-in-Chief, Clinical Journal of the American Society of Nephrology; President-Elect, International Society for Peritoneal Dialysis; Chair, Nephrology Longitudinal Assessment Approval Committee of the American Board of Internal Medicine; Editorial Board for Journal of Renal Nutrition, Peritoneal Dialysis International
Dr. Miller is the Michael A. Kraus Clinical Professor of Medicine at Indiana University and the Kidney Service Line Leader for Indiana University Health Physicians. He leads clinical nephrology at 7 affiliated hospitals, multiple outpatient nephrology clinics and dialysis centers. Prior to arriving at Indiana University, Dr. Miller was a Professor of Medicine at Washington University in St. Louis for over 2 decades where he was active in the kidney transplant program and director of home dialysis modalities. He has served as an investigator in many home dialysis trials, including the Frequent Hemodialysis Network Trial and the NxStage Medical Nocturnal Hemodialysis IDE study for the Food and Drug Administration. He has served on the Scientific Advisory Board of of NxStage Medical and the Medical Advisory Board of Fresenius Kidney Care. He has been active in ongoing home dialysis education educational initiatives such as the Home Dialysis University, Advanced Renal Education Program, Annual Dialysis Conference and the American Society of Nephrology online curriculum. Many of his trainees and mentees have become clinical leaders in home dialysis therapy and is particularly interested in developing the next generation of leaders in home dialysis.
Employer: Indiana University School of Medicine
Ownership Interest: All stock, no stock options. All positions < $20,000 and long; Centene Corporation; Emerson Electric; Toyota; Duke Realty; Ameren; Wisconsin Energy; Puration
Consultancy: Fresenius Medical Services
Advisory or Leadership Role: NxStage Medical Scientific Advisory Board
Dr Jeffrey Perl is a staff nephrologist at St Michael’s Hospital in Toronto and Associate Professor of Medicine at the University of Toronto. He is a prior recipient of The John Maher Young Investigator Award from the International Society for Peritoneal Dialysis and has received several teaching awards at The University of Toronto and St. Michael’s Hospital. His primary research interests, clinical practice and teaching focuses on improving universal access to and clinical outcomes of home dialysis. Dr. Perl is a primary investigator in The International Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) and co-principal investigator of the Optimizing the Prevention of Peritoneal Dialysis-Associated Peritonitis in The United States (OPPUS) study. He also co-chairs The American Society of Nephrology home dialysis steering committee and is previous chair of the ASN home dialysis subcommittee of the American Society of Nephrology COVID-19 response team. He is editor-in-chief of Peritoneal Dialysis International and recently co-chaired The KDIGO Home Dialysis Controversies Conference. He formerly served as chair of the ISN young nephrologists committee and co-chair of the ISN North American Caribbean regional board.
Employer: St. Michael’s Hospital
Consultancy: Baxter Health Care Canada; Bayer, Otsuka, Fresenius Medical Care, Davita Healthcare Partners, ; LiberDi; Astra Zeneca ; Otsuka, Bayer, GSK, Outset
Research Funding: Arbor Research Collaborative For Health; AHRQ
Honoraria: Baxter healthcare usa/canada ; Davita Healthcare partners; Fresenius Medical Care; DCI; , Astra Zeneca, US Renal Care, Bayer Canada, Otsuka. Outset, US Renal Care, Innovative Kidney Care, Liberdi
Speakers Bureau: Baxter Healthcare; Fresenius Medical Care
Other Interests or Relationships: Salary Support: Arbor Research Collaborative For Health; AHRQ
Dr. Matthew Rivara is an Associate Professor of Medicine in the Division of Nephrology at the University of Washington in Seattle, WA. He received his M.D. from Harvard Medical School and completed a residency in internal medicine at Massachusetts General Hospital, followed by clinical and research fellowships in nephrology at the University of Washington. He currently serves as Chief Medical Officer for Northwest Kidney Centers. He is a member of the American Society of Nephrology Quality Committee, and is a core faculty for Home Dialysis University. He is a member of the Education Committee for the International Society for Peritoneal Dialysis, and serves as a Council Member for the ISPD North American Chapter (NAC). His research has focused on clinical and patient-reported outcomes for patients treated with maintenance dialysis, with a focus on home dialysis modalities.
Employer: Northwest Kidney Centers
Advisory or Leadership Role: Editorial Board – CJASN; At large member, North American Chapter Council, International Society of Peritoneal Dialysis
Other Interests or Relationships: National Kidney Foundation Project ECHO
Dr. Anjali Bhatt Saxena, MD is a Clinical Associate Professor of Medicine at Stanford University and Director of Peritoneal Dialysis at Santa Clara Valley Medical Center in San Jose, California. Dr. Saxena completed her BS degree at Duke University and received her MD from Wake Forest University. She completed her Internal Medicine Residency in 2000 at Stanford University, continued on to complete a Postdoctoral Nephrology Fellowship at Stanford University in 2004, and is board certified in Nephrology.
She has served as the Medical Director for an independent Peritoneal Dialysis (PD) Clinic in San Jose, CA since 2004, overseeing a large PD center. She is a dedicated member of the faculty of the Stanford Nephrology Fellowship Program and has received several teaching awards. She is also specifically dedicated to advancing PD and providing education in home dialysis, and as such has been a faculty member of the Home Dialysis University (HDU) since 2007, providing home dialysis education to hundreds of US Nephrologists, Nephrology fellows, and Advanced Practice Practitioners. She joined the HDU Board of Directors in 2021.
She is active on an international stage, having delivered numerous invited lectures at meetings such as ASN-Kidney Week, the Annual Dialysis Conference, and ISPD conferences, and the 2022 ISPD Congress in Singapore. Dr. Saxena is dedicated to the growth and support of PD worldwide; she is the current Treasurer for the International Society for Peritoneal Dialysis (ISPD) since 2018 and is a Past-President of the North American Chapter of the ISPD. She is an Educational Ambassador for the International Society of Nephrology (ISN), and together with her Stanford colleagues has developed a sister-Renal Center program that has grown and supported the growth of a PD program in a low income area of Sri Lanka.
Employer: Stanford University / Santa Clara Valley Med Ctr
Honoraria: Baxter Healthcare; Fresenius Medical Care;
Advisory or Leadership Role: Treasurer, International Society for Peritoneal Dialysis (ISPD) [Board of Directors]
Speakers Bureau: Baxter Healthcare; Fresenius Medical Care
Rebecca Kurnik Seshasai, MD is an Associate Professor of Clinical Medicine at the University of Pennsylvania School of Medicine. She is Medical Director of the Wellbound of Cherry Hill, NJ Home Dialysis unit and serves on the faculty for Home Dialysis University. She obtained her undergraduate degree from the Massachusetts Institute of Technology in Cambridge, MA, her medical degree from Tufts University School of Medicine and completed Internal Medicine residency at Tufts Medical Center, Boston, MA. She moved to Philadelphia to complete a fellowship in Nephrology at The Hospital of the University of Pennsylvania, where she also completed a Masters in Health Policy. Her thesis for this degree was on the discontinuation of home hemodialysis. Her clinical and research interests focus on clinical outcomes in home hemodialysis and peritoneal dialysis. She is a member of American Society of Nephrology, National Kidney Foundation, and International Society for Peritoneal Dialysis. She enjoys teaching and lecturing on home dialysis modalities.
Disclosures: Employer: Hospital of the University of Pennsylvania; Compass; Clearco, Atria
Ownership Interest: Compass; Clearco; Sanderling
Honoraria from Home Dialysis
Dr. Teitelbaum is Professor of Internal Medicine/Nephrology and Director of the Home Dialysis Program at the University of Colorado School of Medicine in Aurora, Colorado. Dr. Teitelbaum has been an active clinical nephrologist for over 35 years. He oversees the care of 50 home dialysis patients in addition to maintaining a busy clinical and consultative practice.
Dr. Teitelbaum serves as a consultant to industry and has actively participated in several clinical trials and numerous educational workshops. He has published or co-authored over 135 articles and/or book chapters and serves as a reviewer for numerous journals.
Dr. Teitelbaum has delivered over 300 presentations at national and international conferences. He is a past- President of the International Society for Peritoneal Dialysis and he has been named as one of Denver’s Top Doctors by 5280 Magazine on numerous occasions.
Employer: University of Colorado Health Science Center
Ownership Interest: LiberDi
Advisory or Leadership Role: Editorial Board of Peritoneal Dialysis International; Associate Editor, Blood Purification
Other Interests or Relationships: Past President of the International Society for Peritoneal Dialysis
Dr. Wallace is a native of Alabama.Dr. Wallace has been medical director of the UAB Home Dialysis program since 2013. He became the Medical Director of Telehealth for the UA Health System in January of 2017 given his work on telehealth for home dialysis and patients with Fabry disease. Under his leadership, numerous outpatient telehealth programs have been initiated and are in process of expanding. The initiation of programs such as telestroke, telecritical, and telenephrology have also resulted in significant improvements in delivery of care and revenue in rural hospitals in Alabama. Dr. Wallace is on the ASN Home Dialysis Committee and is committed to home dialysis and the delivery of highly complex care with as little impact to the patients quality of life as possible.
Employer: University of Alabama at Birmingham
Consultancy: Sanofi-Genzyme; Protalix, Amicus, Chiesi, Idorsia, Natera, Walking Fish
Research Funding: Baxter Healthcare Corp; Sanofi-Genzyme; Protalix; Idorsia
Honoraria: Sanofi-Genzyme; Protalix; Amicus, Idorsia, Chiesi, Natera
Advisory or Leadership Role: North American Fabry Registry Board- Sanofi-Genzyme
Speakers Bureau: Natera